Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 4
2005 6
2006 4
2007 11
2008 10
2009 8
2010 5
2011 8
2012 4
2013 6
2014 12
2015 5
2016 6
2017 5
2018 6
2019 7
2020 5
2021 8
Text availability
Article attribute
Article type
Publication date

Search Results

107 results
Results by year
Filters applied: . Clear all
Page 1
A gain-of-function mutation of JAK2 in myeloproliferative disorders.
Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR, Tichelli A, Cazzola M, Skoda RC. Kralovics R, et al. Among authors: skoda rc. N Engl J Med. 2005 Apr 28;352(17):1779-90. doi: 10.1056/NEJMoa051113. N Engl J Med. 2005. PMID: 15858187 Free article.
Loss of EZH2 Reprograms BCAA Metabolism to Drive Leukemic Transformation.
Gu Z, Liu Y, Cai F, Patrick M, Zmajkovic J, Cao H, Zhang Y, Tasdogan A, Chen M, Qi L, Liu X, Li K, Lyu J, Dickerson KE, Chen W, Ni M, Merritt ME, Morrison SJ, Skoda RC, DeBerardinis RJ, Xu J. Gu Z, et al. Among authors: skoda rc. Cancer Discov. 2019 Sep;9(9):1228-1247. doi: 10.1158/2159-8290.CD-19-0152. Epub 2019 Jun 12. Cancer Discov. 2019. PMID: 31189531 Free PMC article.
Targeting compensatory MEK/ERK activation increases JAK inhibitor efficacy in myeloproliferative neoplasms.
Stivala S, Codilupi T, Brkic S, Baerenwaldt A, Ghosh N, Hao-Shen H, Dirnhofer S, Dettmer MS, Simillion C, Kaufmann BA, Chiu S, Keller M, Kleppe M, Hilpert M, Buser AS, Passweg JR, Radimerski T, Skoda RC, Levine RL, Meyer SC. Stivala S, et al. Among authors: skoda rc. J Clin Invest. 2019 Mar 4;129(4):1596-1611. doi: 10.1172/JCI98785. eCollection 2019 Mar 4. J Clin Invest. 2019. PMID: 30730307 Free PMC article.
Thrombocytosis.
Skoda RC. Skoda RC. Hematology Am Soc Hematol Educ Program. 2009:159-67. doi: 10.1182/asheducation-2009.1.159. Hematology Am Soc Hematol Educ Program. 2009. PMID: 20008195 Review.
The absence of metamictisation in natural monazite.
Nasdala L, Akhmadaliev S, Burakov BE, Chanmuang N C, Škoda R. Nasdala L, et al. Among authors: skoda r. Sci Rep. 2020 Sep 7;10(1):14676. doi: 10.1038/s41598-020-71451-7. Sci Rep. 2020. PMID: 32895406 Free PMC article.
Pathogenesis of myeloproliferative neoplasms.
Skoda RC, Duek A, Grisouard J. Skoda RC, et al. Exp Hematol. 2015 Aug;43(8):599-608. doi: 10.1016/j.exphem.2015.06.007. Epub 2015 Jul 21. Exp Hematol. 2015. PMID: 26209551 Free article. Review.
Chronic myeloproliferative disorders--introduction.
Skoda R, Prchal JT. Skoda R, et al. Semin Hematol. 2005 Oct;42(4):181-3. doi: 10.1053/j.seminhematol.2005.08.004. Semin Hematol. 2005. PMID: 16210031 Review. No abstract available.
Hereditary myeloproliferative disorders.
Skoda RC. Skoda RC. Haematologica. 2010 Jan;95(1):6-8. doi: 10.3324/haematol.2009.015941. Haematologica. 2010. PMID: 20065077 Free PMC article. No abstract available.
107 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page